Cambrex Corp. (CBM)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

ONE MEADOWLANDS PLZ E RUTHERFORD, NJ 07073

Provides products and services to accelerate drug discovery, development and manufacturing processes for human therapeutics. Supplies its products and services worldwide to pharmaceutical and biopharmaceutical companies, generic drug companies, biotechnology companies and research organizations.

View SEC Filings from CBM instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CBM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CBM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KAUFTHAL ILAN

  • Director
0 2019-12-04 1

CAVANAGH SHAWN EVP & COO

  • Officer
0 2019-12-04 1

SARGEN GREGORY CFO & EVP, CORP. DEV.

  • Officer
0 2019-12-04 1

KLOSK STEVEN M PRESIDENT & CEO

  • Officer
  • Director
0 2019-12-04 1

HARRIGAN KATHRYN

  • Director
0 2019-12-04 1

YANAI SHLOMO

  • Director
0 2019-12-04 1

HANLEY SAMANTHA SVP, GENERAL COUNSEL

  • Officer
0 2019-12-04 1

GRABOWSKY LOUIS J.

  • Director
0 2019-12-04 1

GLASSELL CLAES

  • Director
0 2019-12-04 1

HAMPL BERNHARD

  • Director
0 2019-12-04 1

BROWN GREGORY B

  • Director
0 2019-12-04 1

DONNELLY-BRIENZA DOROTHY A SVP & CHRO

  • Officer
0 2019-12-04 1

VADAKETH TOM GEORGE EVP & CFO

  • Officer
0 2018-08-20 0

DIXON ROSINA B

  • Director
84,226 2018-02-12 0

HENDRIX LEON J JR

  • Director
67,301 2017-06-06 0

TOMBROS PETER G

  • Director
24,029 2017-04-27 0

KORB WILLIAM B

  • Director
20,562 2016-07-11 0

MAGNINI ALDO

  • MANAGIN DIRECTOR-PROFARMACO
0 2015-02-12 0

HASKEL WILLIAM M. SENIOR VICE PRESIDENT

  • Officer
0 2014-11-13 0

WINSCHEL JAMES F JR

  • Director
1,350 2014-08-05 0

RUSSOLO PAOLO

  • PRESIDENT, CAMBREX PROFARMACO
73,518 2013-11-22 0

MILLER JOHN R

  • Director
35,306 2013-11-11 0

BETHUNE DAVID R

  • Director
21,116 2012-04-25 0

HALEY ROY W

  • Director
1,356 2009-12-31 0

ZACHARA F. MICHAEL VICE PRESIDENT

  • Officer
0 2009-10-28 0

MACK JAMES A PRESIDENT, CEO & CHAIRMAN

  • Officer
190,734 2008-01-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments